| Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study MJ Armstrong, P Gaunt, GP Aithal, D Barton, D Hull, R Parker, ... The Lancet 387 (10019), 679-690, 2016 | 2003 | 2016 |
| Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial PN Newsome, R Fox, AL King, D Barton, NN Than, J Moore, C Corbett, ... The Lancet Gastroenterology & Hepatology 3 (1), 25-36, 2018 | 159 | 2018 |
| Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response PJ Trivedi, T Bruns, A Cheung, KK Li, C Kittler, T Kumagi, H Shah, ... Journal of hepatology 60 (6), 1249-1258, 2014 | 149 | 2014 |
| Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis R Parker, MJ Armstrong, C Corbett, IA Rowe, DD Houlihan Alimentary pharmacology & therapeutics 37 (9), 845-854, 2013 | 146 | 2013 |
| Mental health disorders and solid-organ transplant recipients C Corbett, MJ Armstrong, R Parker, K Webb, JM Neuberger Transplantation 96 (7), 593-600, 2013 | 128 | 2013 |
| Tobacco smoking and solid organ transplantation C Corbett, MJ Armstrong, J Neuberger Transplantation 94 (10), 979-987, 2012 | 111 | 2012 |
| An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs HJ Cordell, JJ Fryett, K Ueno, R Darlay, Y Aiba, Y Hitomi, M Kawashima, ... Journal of hepatology 75 (3), 572-581, 2021 | 106 | 2021 |
| Postnatal erythropoietin mitigates impaired cerebral cortical development following subplate loss from prenatal hypoxia–ischemia LL Jantzie, CJ Corbett, DJ Firl, S Robinson Cerebral cortex 25 (9), 2683-2695, 2015 | 83 | 2015 |
| Hepatic ischemia reperfusion injury is associated with acute kidney injury following donation after brain death liver transplantation JA Leithead, MJ Armstrong, C Corbett, M Andrew, C Kothari, BK Gunson, ... Transplant international 26 (11), 1116-1125, 2013 | 81 | 2013 |
| Alcohol and substance abuse in solid-organ transplant recipients R Parker, MJ Armstrong, C Corbett, EJ Day, JM Neuberger Transplantation 96 (12), 1015-1024, 2013 | 72 | 2013 |
| Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial MJ Armstrong, D Barton, P Gaunt, D Hull, K Guo, D Stocken, SCL Gough, ... BMJ open 3 (11), e003995, 2013 | 65 | 2013 |
| Near-infrared intraoperative imaging for minimally invasive pulmonary metastasectomy for sarcomas JD Predina, AD Newton, C Corbett, M Shin, LF Sulfyok, OT Okusanya, ... The Journal of thoracic and cardiovascular surgery 157 (5), 2061-2069, 2019 | 61 | 2019 |
| Complex pattern of interaction between in uterohypoxia-ischemia and intra-amniotic inflammation disrupts brain development and motor function LL Jantzie, CJ Corbett, J Berglass, DJ Firl, J Flores, R Mannix, ... Journal of neuroinflammation 11, 1-14, 2014 | 60 | 2014 |
| HTLV-1 in solid-organ transplantation: current challenges and future management strategies MJ Armstrong, C Corbett, IA Rowe, GP Taylor, JM Neuberger Transplantation 94 (11), 1075-1084, 2012 | 60 | 2012 |
| Optimization of second window indocyanine green for intraoperative near-infrared imaging of thoracic malignancy AD Newton, JD Predina, CJ Corbett, LG Frenzel-Sulyok, L Xia, ... Journal of the American College of Surgeons 228 (2), 188-197, 2019 | 55 | 2019 |
| CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease R Parker, CJ Weston, Z Miao, C Corbett, MJ Armstrong, L Ertl, K Ebsworth, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 314 (4 …, 2018 | 55 | 2018 |
| Pharmacokinetics and pharmacodynamics of the non‐nucleoside reverse‐transcriptase inhibitor etravirine in treatment‐experienced HIV‐1‐infected patients TN Kakuda, JR Wade, E Snoeck, P Vis, M Schöller‐Gyüre, MP Peeters, ... Clinical Pharmacology & Therapeutics 88 (5), 695-703, 2010 | 52 | 2010 |
| Greater transplant-free survival in patients receiving obeticholic acid for primary biliary cholangitis in a clinical trial setting compared to real-world external controls CFM Perez, H Fisher, S Hiu, D Kareithi, F Adekunle, T Mayne, E Malecha, ... Gastroenterology 163 (6), 1630-1642. e3, 2022 | 47 | 2022 |
| Operator training requirements and diagnostic accuracy of Fibroscan in routine clinical practice MJ Armstrong, C Corbett, J Hodson, N Marwah, R Parker, DD Houlihan, ... Postgraduate medical journal 89 (1058), 685-692, 2013 | 44 | 2013 |
| Simeprevir in combination with sofosbuvir in treatment‐naïve and‐experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open‐label, single‐arm study (PLUTO) M Buti, JL Calleja, S Lens, M Diago, E Ortega, J Crespo, R Planas, ... Alimentary pharmacology & therapeutics 45 (3), 468-475, 2017 | 43 | 2017 |
Matthew J ArmstrongUniversity Hospital Birmingham在 uhb.nhs.uk 的电子邮件经过验证
